Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Gensia's injectable diltiazem receives ANDA approval

Aug. 28, 1997

Antiarrhythmic effects of 5-HT2 antagonist/TxA2 antagonist combination investigated

Aug. 28, 1997

Parke-Davis initiates QUASAR trial of quinapril

Aug. 28, 1997

Cardiovascular and antiarrhythmic activities of HNS-32

Aug. 27, 1997

Innothera describes agents for venous function deficiency

Aug. 27, 1997

TNF-alpha inhibitors for septic shock and other inflammatory diseases

Aug. 26, 1997

Medtronic initiates U.S. clinical trials of beStent Rival

Aug. 25, 1997

Xoma discloses rBPI-Ig fusion proteins

Aug. 25, 1997

PDGFr tyrosine kinase inhibitor with potential in atherosclerosis

Aug. 25, 1997

Merck KGaA begins development of cardioprotectant

Aug. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...